Searched for
DOMESTIC SOURCING OF INGREDIENTS
UBL sees India as key growth engine for Heineken; focuses on premiumisation, margin expansionUnited Breweries Ltd sees India as central to Heineken's growth agenda. The Indian market is experiencing rising premiumisation and offers ...- Indian FMCG stares at broadening commodity inflation and a new source of cost pressureThe raw-material cost environment for FMCG makers has become increasingly uneven in the second quarter of FY27, with prices of several agri...
- Fevicol maker Pidilite says demand holding steady in Q2; rules out immediate price hikes: MDPidilite Industries expects consumer demand to remain resilient despite inflationary pressures. The company does not foresee immediate pric...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- First US phosphate fertiliser plant since 1984: Morocco’s OCP and CHS plan $450 million, 1-million-tonne Louisiana factory with nearly 1,000 jobsMorocco’s OCP and US farmer-owned cooperative CHS plan a $450 million Louisiana phosphate fertiliser plant, the first of its kind in Americ...
- Sunny side down? Egg prices rise on ethanol pushRising diversion of maize to ethanol production has significantly increased poultry feed costs, leading to a 35-40% surge in egg prices ove...
- ETMarkets Management Talk | CleanMax’s next growth phase: 1.5 GW capacity addition target, Rs 3,000 crore EBITDA by FY28, says Kuldeep JainCleanMax targets 1.5 GW capacity additions in FY27 and over Rs 3,000 crore EBITDA by FY28. Growth is driven by data centres, AI, Make in In...
- Free dhaniya no more? India’s kitchen is feeling a new food squeezeCoriander prices have surged significantly after heavy rains disrupted essential vegetable supplies. Ginger and garlic prices also show sub...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Hormuz uncertainty pushes landed costs up to 50%, raising risk of higher consumer pricesThe escalating unrest near the Strait of Hormuz is causing a notable spike in shipping expenses for businesses in India. An increase in fre...
- US faces new pressure to build weapons without China's rare earth magnetsIn New Hampshire, a forward-thinking company is harnessing electrolysis to extract crucial minerals from mine waste. This initiative is des...
- From protection to competitiveness: How FTAs can help India become a global dairy export leaderFTAs could be used as a catalyst for reforms in India's dairy ecosystem, say experts.
- The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
- The next China shock could be bigger than solar, batteries and EVsChina is emerging as a global leader in humanoid robot manufacturing. The nation's scale and cost reduction strategies are alarming interna...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 26%The US-Iran war continues to create uncertainty for markets across the globe. But more so in India, due to the high correlation between ene...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAfter four days of relative outperformance, the Indian market is seemingly in trouble: Both the indices (the Nifty and Sensex) and market b...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Whether in business or the stock market, be ready for volatility. In today’s world, it can come for any reason and from anywhere. Also be r...
Load More
